Table 4. Epidemiological, Biochemical, and Serological Markers of HBV in 145 Patients With ESRF Grouped by HBV DNA Status (Mean ± SD).
| HBV DNA a Positive (n = 6) | HBV DNA Negative (n = 139) | P value | |
| Age, y, mean ± SD a | 47.2 ± 10.6 | 46.8 ± 10.3 | 0.9 |
| Sex, No. (%) | 0.15 | ||
| Male | 2 (33.3) | (43.6) | |
| Female | 4 (66.7) | (56.4) | |
| Duration of hemodialysis, mo, mean ± SD | 34.2 ± 11.8 | 31.5 ± 10.4 | 0.5 |
| Positive history of transfusion, No, (%) | 6 (100) | 119 (85.6) | 0.1 |
| Positive schistosoma antibodies | 4 (66.6) | 60 (43.1) | 0.77 |
| 2 (33.3) | 79 (56.8) | ||
| AST a , IU/L, mean ± SD | 27 ± 8 | 22 ± 19 | 0.5 |
| ALT a , IU/L, mean ± SD | 28 ± 11 | 26 ± 20 | 0.8 |
| Albumin, g/dL, mean ± SD | 3.46 ± 0.5 | 3.5 ± 0.6 | 0.8 |
| Bilirubin, mean ± SD | 1.4 ± 0.6 | 1.3 ± 0.5 | 0.6 |
| Anti-HBc a positive, No. (%) | 5 (83.3) | 24 (17.2) | 0.003 |
| Anti-HBs positive, No. (%) | 1 (16.6) | 43 (30.9) | 0.1 |
a Abbreviations: ALT, alanine transaminase; Anti-HBc, hepatitis B core antibody; AST, aspartate transaminase; HBV DNA, hepatitis B virus DNA by polymerase chain reaction; SD, standard deviation